Table 2.

Follow-up data

	VTA+ (n = 59)	VTA− (n = 152)	P
Follow-up time (months), median (IQR)	23.7 (14.2–40.4)	15.4 (8.4–33.0)	0.004
Patients experiencing combined outcome, n (%)	5 (8.5)	41 (27.0)	0.004
ICD appropriate shock, n (%)	4 (6.7)	26 (17.1)	0.053
Monomorphic VT, n (%)	1 (1.7)	9 (5.9)	0.194
Cardiovascular death, n (%)	1 (1.7)	13 (8.6)	0.073
Inappropriate shocks, n (%)	3 (5.1)	12 (7.9)	0.478

Statistically significant P values have been boldened.

ICD, implantable cardioverter defibrillator; IQR, inter-quartile range; VT, ventricular tachycardia.